These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1542543)

  • 1. d-Alpha-tocopheryl polyethylene glycol-1000 succinate enhances the absorption of vitamin D in chronic cholestatic liver disease of infancy and childhood.
    Argao EA; Heubi JE; Hollis BW; Tsang RC
    Pediatr Res; 1992 Feb; 31(2):146-50. PubMed ID: 1542543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone disease in chronic childhood cholestasis. II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia.
    Heubi JE; Hollis BW; Tsang RC
    Pediatr Res; 1990 Jan; 27(1):26-31. PubMed ID: 2296467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of vitamin E deficiency during chronic childhood cholestasis with oral d-alpha-tocopheryl polyethylene glycol-1000 succinate.
    Sokol RJ; Heubi JE; Butler-Simon N; McClung HJ; Lilly JR; Silverman A
    Gastroenterology; 1987 Nov; 93(5):975-85. PubMed ID: 3653646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cholestatic children with water-soluble vitamin E (alpha-tocopheryl polyethylene glycol succinate): effects on serum vitamin E, lipid peroxides, and polyunsaturated fatty acids.
    Socha P; Koletzko B; Pawlowska J; Proszynska K; Socha J
    J Pediatr Gastroenterol Nutr; 1997 Feb; 24(2):189-93. PubMed ID: 9106106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis.
    Sokol RJ; Butler-Simon N; Conner C; Heubi JE; Sinatra FR; Suchy FJ; Heyman MB; Perrault J; Rothbaum RJ; Levy J
    Gastroenterology; 1993 Jun; 104(6):1727-35. PubMed ID: 8500733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocopheryl polyethylene glycol 1000 succinate therapy for vitamin E deficiency during chronic childhood cholestasis: neurologic outcome.
    Sokol RJ; Butler-Simon NA; Bettis D; Smith DJ; Silverman A
    J Pediatr; 1987 Dec; 111(6 Pt 1):830-6. PubMed ID: 3681546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral absorbable fat-soluble vitamin formulation in pediatric patients with cholestasis.
    Shen YM; Wu JF; Hsu HY; Ni YH; Chang MH; Liu YW; Lai HS; Hsu WM; Weng HL; Chen HL
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):587-91. PubMed ID: 22595974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism.
    Heubi JE; Hollis BW; Specker B; Tsang RC
    Hepatology; 1989 Feb; 9(2):258-64. PubMed ID: 2783577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of water-soluble vitamin E in the treatment of vitamin E malabsorption in short-bowel syndrome.
    Traber MG; Schiano TD; Steephen AC; Kayden HJ; Shike M
    Am J Clin Nutr; 1994 Jun; 59(6):1270-4. PubMed ID: 8198049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of vitamin E compounds in lambs.
    Hidiroglou N; McDowell LR; Papas AM; Antapli M; Wilkinson NS
    J Anim Sci; 1992 Aug; 70(8):2556-61. PubMed ID: 1506317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E.
    Sokol RJ; Johnson KE; Karrer FM; Narkewicz MR; Smith D; Kam I
    Lancet; 1991 Jul; 338(8761):212-4. PubMed ID: 1676779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D metabolism in biliary atresia: intestinal absorptions of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3.
    Kimura S; Seino Y; Harada T; Nose O; Yamaoka K; Shimizu K; Tanaka H; Yabuuchi H; Fukui Y; Kamata S
    J Pediatr Gastroenterol Nutr; 1988; 7(3):341-6. PubMed ID: 3260278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced solubility and oral absorption of sirolimus using D-α-tocopheryl polyethylene glycol succinate micelles.
    Kim MS; Kim JS; Cho WK; Hwang SJ
    Artif Cells Nanomed Biotechnol; 2013 Apr; 41(2):85-91. PubMed ID: 23305536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of water-miscible forms of vitamin E in a patient with cholestasis and in thoracic duct-cannulated rats.
    Traber MG; Kayden HJ; Green JB; Green MH
    Am J Clin Nutr; 1986 Dec; 44(6):914-23. PubMed ID: 3788838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E (D-alpha-tocopheryl-co-poly(ethylene glycol) 1000 succinate) micelles-superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI.
    Chandrasekharan P; Maity D; Yong CX; Chuang KH; Ding J; Feng SS
    Biomaterials; 2011 Aug; 32(24):5663-72. PubMed ID: 21550654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral vitamin E supplementation in children with cholestasis.
    Roongpraiwan R; Suthutvoravut U; Feungpean B; Phuapradit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1199-205. PubMed ID: 12549795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia.
    Shneider BL; Magee JC; Bezerra JA; Haber B; Karpen SJ; Raghunathan T; Rosenthal P; Schwarz K; Suchy FJ; Kerkar N; Turmelle Y; Whitington PF; Robuck PR; Sokol RJ;
    Pediatrics; 2012 Sep; 130(3):e607-14. PubMed ID: 22891232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of intact TPGS (d-alpha-tocopheryl polyethylene glycol 1000 succinate) a water-miscible form of vitamin E by human cells in vitro.
    Traber MG; Thellman CA; Rindler MJ; Kayden HJ
    Am J Clin Nutr; 1988 Sep; 48(3):605-11. PubMed ID: 3414576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The applications of Vitamin E TPGS in drug delivery.
    Guo Y; Luo J; Tan S; Otieno BO; Zhang Z
    Eur J Pharm Sci; 2013 May; 49(2):175-86. PubMed ID: 23485439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-α-tocopheryl polyethylene glycol 1000 succinate-containing vehicles provide no detectable chemoprotection from oxidative damage.
    Baumgart BR; Van Vleet TR; Simic D; Salcedo TW; Lentz K; Donegan M; Davies MH; Bunch RT; Sanderson TP; Lange RW
    J Appl Toxicol; 2015 Jul; 35(7):791-8. PubMed ID: 25348750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.